Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: A prospective study on patients with HCV related cirrhosis | Zendy

Francesco Azzaroli | Zendy; Esterita Accogli | Zendy; Giovanni Nigro | Zendy; Davide Trerè | Zendy; S. Giovanelli | Zendy; A. Miracolo | Zendy; Francesca Lodato | Zendy; Marco Montagnani | Zendy; Mariarosa Tamè | Zendy; Antonio Colecchia | Zendy; C. Mwangemi | Zendy; Davide Festi | Zendy; Enrico Roda | Zendy; Massimo Derenzini | Zendy; Giuseppe Mazzella | Zendy

Open Access

Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: A prospective study on patients with HCV related cirrhosis

Author(s) -

Francesco Azzaroli,

Esterita Accogli,

Giovanni Nigro,

Davide Trerè,

S. Giovanelli,

A. Miracolo,

Francesca Lodato,

Marco Montagnani,

Mariarosa Tamè,

Antonio Colecchia,

C. Mwangemi,

Davide Festi,

Enrico Roda,

Massimo Derenzini,

Giuseppe Mazzella

Publication year - 2004

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.v10.i21.3099

Subject(s) - ribavirin , medicine , hepatocellular carcinoma , gastroenterology , cirrhosis , hepatitis c virus , hepatitis c , interferon , alpha interferon , prospective cohort study , immunology , virus

To determine the role of interferon (IFN) with or without ribavirin in preventing or delaying hepatocellular carcinoma (HCC) development in patients with hepatitis C virus (HCV) related cirrhosis. Data on the preventive effect of IFN plus ribavirin treatment are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

About

Learn

Discover

Explore